Arvanil, a hybrid endocannabinoid and vanilloid compound, behaves as an antihyperkinetic agent in a rat model of Huntington's disease

  1. De Lago, E.
  2. Urbani, P.
  3. Ramos, J.A.
  4. Di Marzo, V.
  5. Fernández-Ruiz, J.
Revue:
Brain Research

ISSN: 0006-8993

Année de publication: 2005

Volumen: 1050

Número: 1-2

Pages: 210-216

Type: Article

DOI: 10.1016/J.BRAINRES.2005.05.024 GOOGLE SCHOLAR
La source de données: Scopus